@article{article, title  = {{Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 publisher = {{Springer Verlag}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/108863 http://doi.org/10.1007/s40273-016-0440-x }},

 year = {{2017}},

 month = {{1}},

 author = {{Tappenden P and Harnan S and Ren S and Thokala P and Wong R and Mukuria C and Green C and Pledge S and Tidy J}},

 doi = {{10.1007/s40273-016-0440-x}},

 journal = {{PharmacoEconomics}},

 note = {{Accessed on 2025/11/02}}}